Video Game-Like therapy could help older kids with lazy eye
NCT ID NCT07281742
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a home-based video treatment called Curesight for children aged 8 to 12 with amblyopia (lazy eye). The treatment works by showing videos where the stronger eye sees a blurred central area while the weaker eye sees the full clear image, encouraging the brain to use the weaker eye. The goal is to improve vision in the lazy eye. The treatment is already FDA-cleared for younger children, and this study aims to see if it works for older kids as well.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Curesight dichoptic video therapy (device)
What this could lead to
If it works, this could offer an effective at-home treatment option for older children with amblyopia who have not responded to standard therapies.
What could go wrong
This is a small early-phase study with only 30 participants, so results may not apply to all children. The treatment requires consistent use and may not improve vision in every case.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMBLYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Foundation of the Southwest
RECRUITINGDallas, Texas, 75231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••